Oklahoma 2022 2022 Regular Session

Oklahoma Senate Bill SB136 Introduced / Bill

Filed 12/14/2020

                     
 
 
Req. No. 625 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
1st Session of the 58th Legislature (2021) 
 
SENATE BILL 136 	By: Simpson 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to breast and cervical cance r; 
amending 63 O.S. 2011, Section 1 -556, as amended by 
Section 55, Chapter 229, O.S.L. 2013 (63 O.S. Supp. 
2020, Section 1-556), which relates to annual report; 
modifying time period of report; modifying criteria; 
updating statutory refe rences and language; and 
providing an effective date . 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2011, Section 1 -556, as 
amended by Section 55, Chapter 229, O.S.L. 2013 (63 O.S . Supp. 2020, 
Section 1-556), is amended to read as follows: 
Section 1-556. A.  The State Department of Health , giving 
consideration to the recommendations of the Advancement of Wellness 
Advisory Council created in Section 44 of this act Section 1-103a.1 
of this title, shall be responsible for evaluating and repo rting to 
the Governor and the State Commissioner of Health regarding 
contracting for statewide services or issues related to breast 
cancer including, but not limited to:   
 
 
Req. No. 625 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
1.  Mammography and pap sme ar screening of women f or breast and 
cervical cancer as an early detection health care measure, provided 
by facilities which are accredited by national organizations that 
have formed coalitions to issue national cancer screening 
guidelines; 
2.  Medical referral of screened perso ns with abnormal breast 
findings and, to the extent practical, for additional services o r 
assistance for such persons; 
3.  Education and training programs for health care 
professionals to improve methods for the detection and control of 
breast and cervical cancer, and to improve communicatio n with breast 
and cervical cancer patients after dia gnosis; 
4.  Annual public education and awareness campaigns to improve 
the knowledge and health care practices of all Oklahomans with 
respect to breast and cervical can cer; 
5.  Epidemiological trend studi es utilizing the data from the 
Oklahoma Central Canc er Registry for incidence, prevalence and 
survival of breast and cervical cancer victims; and 
6.  Outreach to groups with high proportions of uni nsured and 
underinsured women. 
B.  The evaluative efforts o f the Advisory Committee with 
respect to contracts f or services specified in subsection A of this 
section shall provide appropriate oversight and require ments that 
result in:   
 
 
Req. No. 625 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
1.  Enhanced quality c ontrol standards within facilities which 
perform diagnostic cancer screening for breast and cervical cancer; 
and 
2.  Establishment of a fee schedule for breast and cervical 
cancer screening and diagnosis that com plies with accepted 
Medicare/Medicaid rates and that incorporates a sliding fee payment 
system to encourage self-responsibility. 
C.  The State Department o f Health, giving consideration to the 
recommendations of the Advancement of Wellness Advisory Council 
created in Section 44 of this act Section 1-103a.1 of this title, 
shall report annually to the Governor, the Speaker of the House of 
Representatives, the President Pro Tempore of the Senate, and the 
State Board Commissioner of Health by October 1 of each year every 
fifth year, beginning on October 1, 2021, activities completed 
pursuant to the Oklahoma Breas t and Cervical Cancer Act during the 
prior five (5) fiscal year years, including a report of the funding 
for revolving funds expended on related activities.  The report 
shall may identify populations at highest risk for breast or 
cervical cancer, priority strategies, and emerging technologies, 
including newly introduced therapies and preventive vaccines that 
are effective in preventing and controlling the risk of breast and 
cervical cancer, and any recommendations for ad ditional funding, if 
necessary, to provide screenings and treatment for breast and 
cervical cancer for uninsured and underinsured women.  The report   
 
 
Req. No. 625 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
shall may further recommend strategies or actions to reduce the 
costs of breast and cervical cancer in the State of Oklahoma this 
state. 
D.  The Advancement of Wellness Advisory Council shall eva luate 
the prospective termination or continuation of its ongoing duties on 
October 1, 2008.  Such eva luation shall be made based on the 
successful implementation of breast and cervical cancer reduction 
plans and/or achievement of significant reductions in breast and 
cervical cancer morbidity and mortality in the State of Oklahoma 
this state. 
SECTION 2.  This act shall become effecti ve October 1, 2021. 
 
58-1-625 DC 12/14/2020 11:11:18 AM